869.2000 -5.90 (-0.67%)
NSE Jun 23, 2025 15:31 PM
Volume: 353.3K
 

869.20
-0.67%
ICICI Securities Limited
EBITDA margins improved 723 bps YoY to 50% (I-direct estimate: 57.6%) mainly due to better realisation from limited competition launches in the US. However, it was below I-direct estimates mainly due to lower gross margins (84% vs. I-direct estimate of 90%) Adjusted net profit increased 69.7% YoY to | 300 crore (I-direct...
Natco Pharma Ltd. has an average target of 1297.50 from 4 brokers.
More from Natco Pharma Ltd.
Recommended